Law firm Slater & Gordon is investigating a shareholder class action against Australiaās largest onshore oil producer Beach Energy, following a significant decline in its projected earnings from oil reserves on the Western Flank in South Australia.
Slater and Gordon principal Kaitlin Ferris leadership prowess extends beyond the world of class actions, with the natural born leader also earning praise for “walking the walk” on equitable briefing and diversity.
A judge has gutted a defence and counterclaim filed by the biggest unitholder in investment fund Vale in a battle with a litigation funder and liquidators over agreements to join two class actions against S&P Capital, a fight that threatened to hold up one of the class actions.
A Federal Court judge has made his feelings known about a ruling by the NSW Supreme Court last year that found judges have no power to shut unregistered group members out of a class action, but said he was ājust a single judgeā and was bound by the decision.
Change has never fazed Slater and Gordon practice group leader Mathew Chuk, who has used the ever-evolving class action world and tumultuous times at his law firm to build an impressive career.
Plaintiffs law firm Slater & Gordon is considering a shareholder class action against the a2 Milk company over its 2021 financial year guidance, which was downgraded after weak baby formula sales to China.
Lawyerly is pleased to announce the winners of its inaugural Litigation Rising Stars competition, which honours 30 lawyers under the age of 40 for their work in high-stakes litigation.
The stage is set for a beauty parade of two shareholder class actions against Freedom Foods and Deloitte, and the judge overseeing the cases has embraced the recommendation of the High Court to appoint an independent barrister to represent group members in the contest.
The lead applicant in a class action against Bayer over its allegedly defective Essure contraceptive devices has won court approval to drop her consumer law claims against the German drug maker, with a judge agreeing that the plaintiff’s defect and negligence claims had a better chance of succeeding.
Costly add-on therapies sold by Monash IVF to thousands of women undergoing IVF — including pre-implantation genetic testing — are the targets of a new class action investigation.